• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/22

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

22 Cards in this Set

  • Front
  • Back
amino steroid based NMJ blocker suffix
-curonium
amino steroid based NMJ blockers-
(4) (metabolism, elimination, type)
ideal NMJ blocker
non-depolarizing
metabolically inactivated
rapidly eliminated
example of amino steroid NMJ blocker?
malouetine
pancuronium- duration, AE (2)
longer acting agent
cause increase in BP
contraindicated in CAD
vecuronium - duration
CV side fx
intermediate duration
no significant CV side effects
pipcuronium- duration
longer acting
rocuronium- duration
onset
intermediate duration
rapid onset
tetrahydroisoquinoline- based NMJs suffix
-curium
tetrahydroisoquinoline- type of drug
structure (3)
non depolarizing NMJ blocker
long connecting chain
generally contain esters which are hydrolyzed
aliphatic diester structure
metabolism of atracurium (4)
esters rapidly hydrolyzed
not metabolized by kidney or liver
can decompose via hoffman elimination (nonenzymatic base catalyzed decomposition- yields laundanosine, which is inactive)
useful in pt with renal/hepatic disease
atracurium type of drug
non depolarizing
laudanosine (2)
metabolite via hoffman elimination of atracurium

toxic- decreases seizure threshold
ester location in relation to quat ammonium on atracurium
2 Cs away...?
2 means of metabolism of atracurium
ester hydrolysis
hoffman elimination
describe hoffman elimination of atrcurium and it's products
hoffmann: no hydrolysis- just cleaves off the ring structures on the ends of molecules, forming laudanosine x2 and the middle aliphatic ester chain ends up with 2 dbl bonds on the ends + esters
describe ester hydrolysis of atracurium and it's products
ring structures hydrolyzed off as quat ammonium carboxylic acids x2 + diol
mivacurium SAR and what this implies for isomerism
has a dbl bond in middle- thus can have cis/trans


mix of 3 different isomers: cis-trans, trans-trans, cis-cis
mivacurium- potency of isomers (3)
cis-trans
trans-trans

these are both potency (equipotent)

cis-cis has little potency
ester in relation to quat amine for mivacurium and what this implies for metabolis
3 Cs away (vs. atracurium which was 2)

thus does not undergo hoffman elimination
doxcurium- metabolism, duration, AE vs other tetrahydroiso NMJs
no hoffman elimination (3Cs away from quat amine)

longer acting

no CV AE
therapeutic apps of NMJs (3)
NMJ blockers are adjunct to general anesthesia
reduce depth of anesthesia neccessary
decrease risk, quicker recovery time
side effects of NMJs (3) and Mechanism of these AEs
hypotension
bronchospasm
cardiac disturbances
depolarizing agents release histamine- which is what causes these AEs